
Abbott Labs (ABT) Stock Forecast & Price Target
Abbott Labs (ABT) Analyst Ratings
Bulls say
Abbott Laboratories is positioned for strong growth potential in the medical device and diagnostics markets, with key products in cardiovascular and diabetes devices, adult and pediatric nutritional products, and diagnostic equipment. The company's recent launch of the Volt PFA system has shown success in both the US and Europe, with expectations of being a leading player in Europe and targeting a US launch in Q3. The company's strong investments in manufacturing and pipeline development show potential for continued success in the future. Overall, Abbott's well-rounded business model, strong cash generation, and focus on high-growth areas make it a compelling investment opportunity.
Bears say
Abbott Laboratories is facing several fundamental challenges that are negatively impacting its stock outlook. These include a highly competitive market for its medical devices and diagnostics products, potential market shifts due to healthcare policy changes, and risks from tariffs and litigation. The company's nutritional products segment has also seen declining sales and is undergoing a transition period which could further impact its revenue and profitability. While the company has made efforts to drive growth in high-growth areas such as diabetes and structural heart devices, there are concerns about the company's ability to sustain strong EPS growth and generate robust cash flow. These factors have contributed to a negative outlook for the company's stock.
This aggregate rating is based on analysts' research of Abbott Labs and is not a guaranteed prediction by Public.com or investment advice.
Abbott Labs (ABT) Analyst Forecast & Price Prediction
Start investing in Abbott Labs (ABT)
Order type
Buy in
Order amount
Est. shares
0 shares